Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS
阿扎胞苷治疗可使难治性血管免疫母细胞性T细胞淋巴瘤（AITL）在无TET2突变或合并骨髓增生异常综合征（MDS）的情况下快速且持久地达到完全缓解。
期刊:Hemasphere
影响因子:14.6
doi:10.1097/HS9.0000000000000187
Gregory, Gareth P; Dickinson, Michael; Yannakou, Costas K; Wong, Jonathan; Blombery, Piers; Corboy, Greg; Kats, Lev; Crozier, Tim M E; Kumar, Beena; Prince, H Miles; Opat, Stephen S; Shortt, Jake
